Inpharma Weekly

, Volume 1057, Issue 1, pp 22–22 | Cite as

FDA committee finds in favour of ‘Copaxone’

Newsletter Article


Central Nervous System Multiple Sclerosis Systemic Reaction Advisory Committee Committee Member 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1996

Personalised recommendations